Reuters logo
BRIEF-Hologic to divest blood screening business to partner Grifols for $1.85 bln
December 14, 2016 / 9:33 PM / a year ago

BRIEF-Hologic to divest blood screening business to partner Grifols for $1.85 bln

Dec 14 (Reuters) - Hologic Inc

* Expects to update its financial guidance for fiscal 2017 after transaction closes

* Transaction has been approved by boards of directors of both companies.

* For fiscal 2017 co’s share of blood screening business was forecast to contribute $240 million revenue, GAAP EPS of $0.19, and non-GAAP EPS of $0.34

* Hologic to divest blood screening business to partner Grifols for $1.85 billion Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below